Johnson & Johnson has unveiled groundbreaking findings on nipocalimab, an investigational FcRn blocker, in a recent ...

Mumbai: A 64-year-old woman from Andheri East, Mumbai, has fully recovered from Guillain-Barré Syndrome (GBS) after weeks of ...

Investigators from Shanghai, China, report responses above 90% by using levantinib and tislelizumab to treat patients with a ...

More than a decade after hosting clinical trials for two medications now commonly used to slow the progression of Alzheimer’s ...

GU ASCO annual meeting featured a kidney cancer trials in progress session and a presentation by Dr. Eric Jonasch discussing a phase 1b/2 study of combination 177Lu girentuximab + cabozantinib and ...